ArticleJournal of clinical medicine2024

Glucose-Lowering Drugs with Proven Cardiovascular Benefit Following Acute Coronary Syndrome in Patients with Type 2 Diabetes: Treatment Gaps and Outcomes.

Ibrahim Naoum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.